Identify LXR target gens that are involved in migration and invasion phenotype Overall design: PC3 prostate cancer cell were treated for 24h with DMSO or GW3965 1µM in RPMI-1640, L-Glu 2mM after overn
log2 fold change of six selected patients at time points 6 h, 12 h, 24 h, 48 h and 72 h. Data were taken from [20], Affymetrix probe IDs are shown. Table S2. Time-course and patient- dependent cluster
